Likewise, changes in the melanopsin function were reported in neurological and psychiatric conditions including Parkinson’s disease (Joyce et al., 2018), multiple sclerosis (Meltzer et al., 2017), and depressive disorder (Feigl et al., 2018). This evidence concerns the gene OPN4 and multiple sclerosis.